N/A N=12 Erectile Rating During the Treatment of Rectal Cancers Localized
Rectal Cancer Stage I
Primary: Proportion of Patients With Erectile Dysfunction Induced by Medical and Surgical Treatment of Rectal Cancer — 0 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=80 Radial Shockwave Therapy for Erectile Dysfunction
Erectile Dysfunction
Primary: Change IIEF-EF Score — 3.4; 4.2 units on a scale
Phase 2 N=20 Mirabegron For Erectile Dysfunction
Erectile Dysfunction · Overactive Bladder · Urinary Incontinence
Primary: Erectile Function Assessed by IIEF Questionnaire — 12.7 score on a scale
Phase 3 N=618 Treatment of Erectile Dysfunction I
Erectile Dysfunction
Primary: Change in Erectile Function Domain Assessed by International Index of Erectile Function (IIEF), Baseline to Final Visit/Week 12, mITT (Modified Intent-to-Treat), LOCF…
Phase 4 N=623 A Study in Erectile Dysfunction
Erectile Dysfunction
Primary: Percentage of Participants Having an International Index of Erectile Function - Erectile Function (IIEF-EF) Domain Score Greater Than or Equal to 26 Through 12-Week…
Phase 4 N=440 Research Evaluating a PDE5 Inhibitor for Erectile Dysfunction
Erectile Dysfunction
Primary: Per-subject Proportion of Sexual Attempts That Had an Erectogenic Effect Within Approximately 15 Minutes Following Dosing — 14.9; 25.9; 29.1 percentage of successes
Phase 3 N=601 Treatment of Erectile Dysfunction II
Erectile Dysfunction
Primary: Change in Erectile Function Domain Assessed by International Index of Erectile Function (IIEF), Baseline to Final Visit/Week 12, mITT (Modified Intent-to-Treat), LOCF…
N/A N=20 MED3000 Topical Gel for On-Demand Treatment of Post-Radical Prostatectomy Erectile Dysfunction
Erectile Dysfunction Following Radical Prostatectomy
Primary: Whether the Erectile Function Domain of the International Index of Erectile Function Mean Change From Baseline Met or Exceeded the Minimally Clinically Important…
N/A N=98,832 Identification of Underlying Conditions in Men Prescribed a PDE5 Inhibitor
Erectile Dysfunction · Cardiovascular Diseases · Male Urogenital Diseases
Primary: Percentage of Participants With Underlying Condition Until Day -1 of the Index PDE5i Prescription — 70.23; 55.73 Percentage of participants — p=<0.001
N/A N=103 Safety and Efficacy of Low Intensity Shockwave for the Treatment of Erectile Dysfunction
Vasculogenic Erectile Dysfunction
Primary: International Index of Erectile Function (IIEF-EF) Questionnaire — 18; 17.9; 20.5; 19.7 score on a scale — p=<0.007
Phase 1 N=59 Shockwave Therapy and Platelet Rich Plasma for the Treatment of Erectile Dysfunction
Erectile Dysfunction
Primary: Number of Participants With Treatment Emergent Serious Adverse Events (TE-SAEs) During the Study Period. — 0; 0 Participants
Phase 4 N=140 Effect of Testosterone in Men With Erectile Dysfunction
Erectile Dysfunction · Testosterone Deficiency · Diabetes
Primary: Change From Baseline in Erectile Function Domain Score of the International Index of Erectile Function (IIEF) — 19.6; 20.1; 21.3; 21.3 units on a scale
Phase 3 N=70 Botulinum Toxin for Erectile Dysfunction
Sexual Dysfunction · Erectile Dysfunction
Primary: Right (PSV R) and Left (PSV L) Cavernosal Artery Mean PSV Before Treatment — 34.52; 30.85; 34.33; 31.73 cm/sec
Phase 3 N=646 Research Evaluating an Investigational Medication for Erectile Dysfunction - General ED
Erectile Dysfunction
Primary: Change in Percentage of Sexual Attempts in Which Subjects Were Able to Maintain an Erection of Sufficient Duration to Have Successful Intercourse — 14.1; 27.8; 43.4…
Phase 4 N=372 A Study in Erectile Dysfunction
Erectile Dysfunction
Primary: Earliest Onset Day Measured by Cumulative Percentage of Participants With Yes Response to Sexual Encounter Profile Diary Question 3 — 54.5; 62.2; 47.2; 49.1 cumulative…
Phase 3 N=390 Research Evaluating an Investigational Medication for Erectile Dysfunction - Diabetic ED (REVIVE-D)
Erectile Dysfunction
Primary: Change in Percentage of Sexual Attempts in Which Subjects Were Able to Maintain an Erection of Sufficient Duration to Have Successful Intercourse — 13.6; 28.7; 34.0…
Phase 3 N=74 An Efficacy Study to Evaluate Alfuzosin to Treat Men With Erectile Dysfunction and Mild Lower Urinary Tract Symptoms
Erectile Dysfunction · Lower Urinary Tract Symptoms
Primary: Change From Baseline Erectile Function Domain of the International Index of Erectile Function — 2.84; 2.84 Change in EF Domain Score from Baseline
Phase 3 N=192 Clinical Investigation Using MED3000 Gel or Tadalafil Tablets in the Treatment of Erectile Dysfunction
Erectile Dysfunction
Primary: Change From Baseline in the Erectile Function (EF) Domain of the International Index of Erectile Function (IIEF) Questionnaire, in Patients Randomised to MED3000, at…
Phase 3 N=298 Research Evaluating an Investigational Medication for Erectile Dysfunction - Post-Prostatectomy
Erectile Dysfunction
Primary: Change in Percentage of Sexual Attempts in Which Subjects Are Able to Maintain an Erection of Sufficient Duration to Have Successful Intercourse — 13.9; 28.0; 29.4…
Phase 2 N=232 Clinical Trial of Topically-applied Glyceryl Trinitrate (GTN) for the Treatment of Erectile Dysfunction (ED)
Erectile Dysfunction
Primary: Erectile Function (EF) Domain Score of the International Index of Erectile Function (IIEF) — 18.5; 19.6 score on a scale — p=0.0132
Phase 4 N=150 Study of Vardenafil in Patients Suffering From Erectile Dysfunction and Metabolic Syndrome
Erectile Dysfunction · Metabolic Syndrome
Primary: Change From Baseline in International Index of Erectile Function - Erectile Function Domain (IIEF-EF) Subscore at Week 8 or Last Observation Carried Forward (LOCF)…
Phase 4 N=176 Impact Of Viagra On Sexual Satisfaction Of Men With Mild Erectile Dysfunction Who Are Sexually Dissatisfied
Impotence
Primary: Erectile Dysfunction Inventory of Treatment Satisfaction (EDITS) Index at the End of the DB Treatment (Week 8) — 80.27; 62.15 scores on a scale — p=<0.0001
Phase 2 N=894 A Study of LY900010 in Erectile Dysfunction
Erectile Dysfunction
Primary: Change From Baseline to 12 Week Endpoint in International Index of Erectile Function (IIEF) Erectile Function (EF) Domain Score — 2.515; 2.405; -0.971; 3.530 units on a…
N/A N=6 Low Intensity Shock Wave Therapy in the Management of Erectile Dysfunction
Erectile Dysfunction
Primary: Change in Right Resistive Index — 75.67 cm/second
Phase 2 N=61 Safety and Efficacy of Autologous Platelet-Rich Plasma for Erectile Dysfunction.
Erectile Dysfunction
Primary: Number of Participants Achieving MCID in IIEF-EF. — 14; 15; 10; 13 Participants
N/A N=80 A Trial to Evaluate the Efficacy and Safety of EFLA400 Korea Red Ginseng Extract on Sexual Function in Men With Erectile Dysfunction
Healthy Subjects(Only Men)
Primary: Changes in EF(Erectile Function) Domain — 11.53; 12.89; 14.56; 16.46 Scores on a scale
Phase 4 N=383 A Study of Tadalafil and Sildenafil in Men With Erectile Dysfunction in China
Erectile Dysfunction
Primary: Percentage of Participants Preferring Tadalafil Over Sildenafil Measured at Week 18 Using Question 1 of the "Phosphodiesterase 5 Inhibitor Treatment Preference"…
Phase 2 N=14 Pentoxifylline, Atorvastatin, and Vitamin E in Treating Patients With Erectile Dysfunction After Radiation Therapy for Prostate Cancer
Male Erectile Disorder · Prostate Adenocarcinoma · Erectile Dysfunction, CTCAE
Primary: Change in International Index of Erectile Function (IIEF) Scores — 0; 0; 0 Participants
Phase 3 N=342 Tadalafil Taken Daily Compared to Placebo on Improvement of Getting and Maintaining an Erection and Sexual Quality of Life
Impotence
Primary: Change From Baseline to Endpoint in the International Index of Erectile Function (IIEF)- Erectile Function Domain Score (Sum of IIEF Questions 1-5 and 15) — 0.49; 8.03…
Phase 3 N=290 Study of Sildenafil Citrate During and After Radiotherapy/Hormone Therapy for Erectile Function Versus Radiotherapy/Hormone Therapy for Prostate Cancer
Prostate Cancer · Erectile Dysfunction
Primary: Assessment of Erectile Dysfunction — 64; 64; 59.00; 58 units on a scale